These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16681724)

  • 1. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters?
    Ozel E; Peştereli HE; Simşek T; Erdoğan G; Karaveli FS
    Int J Gynecol Cancer; 2006; 16(2):549-55. PubMed ID: 16681724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
    Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
    Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
    Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
    J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma.
    Li W; Xu RJ; Jiang LH; Shi J; Long X; Fan B
    Med Oncol; 2005; 22(1):63-70. PubMed ID: 15750198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance.
    Hara A; Okayasu I
    Acta Neuropathol; 2004 Jul; 108(1):43-8. PubMed ID: 15088099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of COX-2 and iNOS in Angiogenesis of Superficial Esophageal Squamous Cell Carcinoma.
    Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H
    Int Surg; 2015 Apr; 100(4):733-43. PubMed ID: 25875558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis.
    Cianchi F; Cuzzocrea S; Vinci MC; Messerini L; Comin CE; Navarra G; Perigli G; Centorrino T; Marzocco S; Lenzi E; Battisti N; Trallori G; Masini E
    Dig Liver Dis; 2010 Jan; 42(1):20-7. PubMed ID: 19497798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
    Gynecol Oncol; 2004 Mar; 92(3):806-12. PubMed ID: 14984945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
    Saied EM; El-Etreby NM
    Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.
    Kasper HU; Wolf H; Drebber U; Wolf HK; Kern MA
    World J Gastroenterol; 2004 Jul; 10(13):1918-22. PubMed ID: 15222037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
    Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer.
    Kong G; Kim EK; Kim WS; Lee KT; Lee YW; Lee JK; Paik SW; Rhee JC
    J Gastroenterol Hepatol; 2002 Aug; 17(8):914-21. PubMed ID: 12164968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-2 in ovarian serous carcinoma: correlation with angiogenesis, nm23 expression and survival.
    Ozuysal S; Bilgin T; Ozgur T; Celik N; Evrensel T
    Eur J Gynaecol Oncol; 2009; 30(6):640-5. PubMed ID: 20099494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.
    Rahman MA; Dhar DK; Yamaguchi E; Maruyama S; Sato T; Hayashi H; Ono T; Yamanoi A; Kohno H; Nagasue N
    Clin Cancer Res; 2001 May; 7(5):1325-32. PubMed ID: 11350902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homeoprotein DLX4 controls inducible nitric oxide synthase-mediated angiogenesis in ovarian cancer.
    Trinh B; Ko SY; Haria D; Barengo N; Naora H
    Mol Cancer; 2015 Apr; 14():97. PubMed ID: 25924901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between inducible nitric oxide synthase and cyclooxygenase-2 expression in human colorectal adenocarcinoma: a cross-sectional study.
    Habibollahi P; Jamshidiha M; Daryani NE; Jahanzad I; Ghahremani MH; Ostad SN
    Pathol Oncol Res; 2010 Sep; 16(3):327-35. PubMed ID: 20069397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.
    Vakkala M; Kahlos K; Lakari E; Pääkkö P; Kinnula V; Soini Y
    Clin Cancer Res; 2000 Jun; 6(6):2408-16. PubMed ID: 10873093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours.
    Sakamoto A; Yokoyama Y; Umemoto M; Futagami M; Sakamoto T; Bing X; Mizunuma H
    Br J Cancer; 2004 Aug; 91(4):633-8. PubMed ID: 15266333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of EGFR expression with angiogenesis and chemoresistance in ovarian carcinoma].
    Chen AP; Zhang J; Liu H; Zhao SP; Dai SZ; Sun XL
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):48-52. PubMed ID: 19538870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.